| Metric | Q4'25 | Q1'26 | Change |
|---|---|---|---|
| Revenue | $2.0B (Q4 2025, +13% YoY) | $1.93B (Q1 2026, +11% YoY) | Solid double-digit growth continues |
| Organic Revenue Growth | 5% (Q4 2025) | 5% (Q1 2026) | Stable but EIG/EMG mix shifting |
| EPS | $2.01 (Q4 2025, +7% YoY) | $1.97 (Q1 2026, +13% YoY) | +600 bps acceleration in earnings growth |
| Operating Income | $523M (Q4 2025, +12% YoY) | $517M (Q1 2026, +14% YoY) | +200 bps acceleration |
| Core Operating Margins | 27.6% (Q4 2025, +100 bps YoY) | 27.9% (Q1 2026, +160 bps YoY) | Margin expansion accelerating |
| Orders | $2.0B (Q4 2025, +18% YoY) | $2.2B (Q1 2026, +23% YoY) | Record quarter, +500 bps acceleration |
| Organic Orders Growth | 7% (Q4 2025) | 22% (Q1 2026) | Explosive +1500 bps acceleration |
| Backlog | $3.58B (Q4 2025) | $3.87B (Q1 2026) | +$290M increase, record high |
| EIG Organic Orders | Not disclosed specifically | +25% (Q1 2026) | First time breaking this out - massive |
| EMG Organic Orders | Not disclosed specifically | +16% (Q1 2026) | Still strong but EIG now leading |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.